Stanford MicroArray Database
WORLD
  Password   
Sign Out

Stanford Microarray Database
 

 

Recent Publications

Regulation of interferon response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. van Baarsen LG, et al. (2010) Arthritis Res Ther 12(1):R11

IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients. Rajski M, et al. (2010) BMC Med 8(1):1

Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. Forsberg EC, et al. (2010) PLoS One 5(1):e8785

Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Thompson LJ, et al. (2009) Proc Natl Acad Sci U S A 106(52):22433-22438

Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. Hendrickson DG, et al. (2009) PLoS Biol 7(11):e1000238

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Beck AH, et al. (2009) Oncogene ():

Industrial fuel ethanol yeasts contain adaptive copy number changes in genes involved in vitamin B1 and B6 biosynthesis. Stambuk BU, et al. (2009) Genome Res 19(12):2271-8

A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol. Nesbitt NM, et al. (2010) Infect Immun 78(1):275-82

Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer. Buess M, et al. (2009) Neoplasia 11(10):987-1002

The transcriptional regulator Rv0485 modulates the expression of a pe and ppe gene pair and is required for Mycobacterium tuberculosis virulence. Goldstone RM, et al. (2009) Infect Immun 77(10):4654-67

Combination of host susceptibility and Mycobacterium tuberculosis virulence define gene expression profile in the host. Beisiegel M, et al. (2009) Eur J Immunol 39(12):3369-3384

Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity. Murry JP, et al. (2009) J Infect Dis 200(5):774-82